Format
Sort by
Items per page

Send to

Choose Destination

Links from Protein

Items: 1 to 20 of 473

1.

Multiple single nucleotide polymorphisms in the first intron of the IL2RA gene affect transcription factor binding and enhancer activity.

Schwartz AM, Demin DE, Vorontsov IE, Kasyanov AS, Putlyaeva LV, Tatosyan KA, Kulakovskiy IV, Kuprash DV.

Gene. 2017 Feb 20;602:50-56. doi: 10.1016/j.gene.2016.11.032.

PMID:
27876533
2.

The Diagnostic and Prognostic Value of sIL-2R as an Immune Biomarker in Head and Neck Cancers.

Gross M, Meirovich A, Rachmut J, Kalichman I, Peretz T, Eliashar R, Barak V.

Anticancer Res. 2016 Aug;36(8):4347-52.

PMID:
27466555
3.

Enhanced pretreatment CD25 expression on peripheral blood CD4+ T cell predicts shortened survival in acute myeloid leukemia patients receiving induction chemotherapy.

Bołkun Ł, Rusak M, Eljaszewicz A, Pilz L, Radzikowska U, Łapuć I, Łuksza E, Dąbrowska M, Bodzenta-Łukaszyk A, Kłoczko J, Moniuszko M.

Pharmacol Rep. 2016 Feb;68(1):12-9. doi: 10.1016/j.pharep.2015.05.025.

PMID:
26721345
4.

CD25 expression on residual leukemic blasts at the time of allogeneic hematopoietic stem cell transplant predicts relapse in patients with acute myeloid leukemia without complete remission.

Ikegawa S, Doki N, Kurosawa S, Yamaguchi T, Sakaguchi M, Harada K, Yamamoto K, Hino Y, Shingai N, Senoo Y, Hattori K, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Haraguchi K, Okuyama Y, Ohashi K.

Leuk Lymphoma. 2016;57(6):1375-81. doi: 10.3109/10428194.2015.1099644.

PMID:
26422713
5.

Prognostic Relevance of Cytokine Receptor Expression in Acute Myeloid Leukemia: Interleukin-2 Receptor α-Chain (CD25) Expression Predicts a Poor Prognosis.

Nakase K, Kita K, Kyo T, Ueda T, Tanaka I, Katayama N.

PLoS One. 2015 Sep 16;10(9):e0128998. doi: 10.1371/journal.pone.0128998.

6.

IL2RA is associated with persistence of rheumatoid arthritis.

van Steenbergen HW, van Nies JA, Ruyssen-Witrand A, Huizinga TW, Cantagrel A, Berenbaum F, van der Helm-van Mil AH.

Arthritis Res Ther. 2015 Sep 8;17:244. doi: 10.1186/s13075-015-0739-6.

7.

Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity.

Kreitman RJ, Stetler-Stevenson M, Jaffe ES, Conlon KC, Steinberg SM, Wilson W, Waldmann TA, Pastan I.

Clin Cancer Res. 2016 Jan 15;22(2):310-8. doi: 10.1158/1078-0432.CCR-15-1412.

8.

Plasma Levels of Soluble Interleukin-2 Receptor α: Associations With Clinical Cardiovascular Events and Genome-Wide Association Scan.

Durda P, Sabourin J, Lange EM, Nalls MA, Mychaleckyj JC, Jenny NS, Li J, Walston J, Harris TB, Psaty BM, Valdar W, Liu Y, Cushman M, Reiner AP, Tracy RP, Lange LA.

Arterioscler Thromb Vasc Biol. 2015 Oct;35(10):2246-53. doi: 10.1161/ATVBAHA.115.305289.

9.

Association of common polymorphisms in the IL2RA gene with type 1 diabetes: evidence of 32,646 individuals from 10 independent studies.

Tang W, Cui D, Jiang L, Zhao L, Qian W, Long SA, Xu K.

J Cell Mol Med. 2015 Oct;19(10):2481-8. doi: 10.1111/jcmm.12642.

10.

Membrane protrusion powers clathrin-independent endocytosis of interleukin-2 receptor.

Basquin C, Trichet M, Vihinen H, Malardé V, Lagache T, Ripoll L, Jokitalo E, Olivo-Marin JC, Gautreau A, Sauvonnet N.

EMBO J. 2015 Aug 13;34(16):2147-61. doi: 10.15252/embj.201490788.

11.

Serum level of soluble interleukin-2 receptor correlates with CD25 expression in patients with T lymphoblastic lymphoma.

Toji T, Takata K, Sato Y, Miyata-Takata T, Hayashi E, Habara T, Maeda Y, Tanimoto M, Yoshino T.

J Clin Pathol. 2015 Aug;68(8):622-7. doi: 10.1136/jclinpath-2015-202934.

PMID:
25935549
12.

Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients.

Mirjačić Martinović K, Babović N, Džodić R, Jurišić V, Matković S, Konjević G.

J Transl Med. 2015 Apr 14;13:120. doi: 10.1186/s12967-015-0479-z.

13.

Immune derangements in patients with myelofibrosis: the role of Treg, Th17, and sIL2Rα.

Wang JC, Sindhu H, Chen C, Kundra A, Kafeel MI, Wong C, Lichter S.

PLoS One. 2015 Mar 20;10(3):e0116723. doi: 10.1371/journal.pone.0116723.

14.

Discrepant elevation of sIL-2R levels in sarcoidosis patients with renal insufficiency.

Verwoerd A, Vorselaars AD, van Moorsel CH, Bos WJ, van Velzen-Blad H, Grutters JC.

Eur Respir J. 2015 Jul;46(1):277-80. doi: 10.1183/09031936.00005315. No abstract available.

15.

Ultra-high level of serum soluble interleukin-2 receptor at diagnosis predicts poor outcome for angioimmunoblastic T-cell lymphoma.

Shiratori S, Kosugi-Kanaya M, Shigematsu A, Kobayashi H, Yamamoto S, Kobayashi N, Iwasaki H, Mori A, Kunieda Y, Yutaka T, Kurosawa M, Kakinoki Y, Endo T, Kondo T, Hashino S, Teshima T; North Japan Hematology Study Group (NJHSG)..

Leuk Lymphoma. 2015;56(9):2592-7. doi: 10.3109/10428194.2014.1001985.

PMID:
25563559
16.

Diesel exhaust particle exposure in vitro impacts T lymphocyte phenotype and function.

Pierdominici M, Maselli A, Cecchetti S, Tinari A, Mastrofrancesco A, Alfè M, Gargiulo V, Beatrice C, Di Blasio G, Carpinelli G, Ortona E, Giovannetti A, Fiorito S.

Part Fibre Toxicol. 2014 Dec 14;11:74. doi: 10.1186/s12989-014-0074-0.

17.

In vivo maintenance of human regulatory T cells during CD25 blockade.

Huss DJ, Mehta DS, Sharma A, You X, Riester KA, Sheridan JP, Amaravadi LS, Elkins JS, Fontenot JD.

J Immunol. 2015 Jan 1;194(1):84-92.

18.

Expression of CD25 is a specific and relatively sensitive marker for the Philadelphia chromosome (BCR-ABL1) translocation in pediatric B acute lymphoblastic leukemia.

Gaikwad AS, Donohue RE, Elghetany MT, Sheehan AM, Lu XY, Gramatges MM, McClain KL, Mistretta TA, Punia JN, Moore TJ, Goltsova T, Cubbage M, Curry CV.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):6225-30.

19.

Clinical impact of CD25 expression on outcomes of allogeneic hematopoietic stem cell transplant for cytogenetically intermediate-risk acute myeloid leukemia.

Ikegawa S, Doki N, Yamamoto K, Shingai N, Takahashi Y, Aoki J, Yoshioka K, Narukawa K, Ishida S, Igarashi A, Oshikawa G, Kobayashi T, Kakihana K, Sakamaki H, Haraguchi K, Okuyama Y, Ohashi K.

Leuk Lymphoma. 2015 Jun;56(6):1874-7. doi: 10.3109/10428194.2014.974044. No abstract available.

PMID:
25311493
20.

Urinary sCD25 as a biomarker of lupus nephritis disease activity.

Gupta R, Yadav A, Misra R, Aggarwal A.

Lupus. 2015 Mar;24(3):273-9. doi: 10.1177/0961203314555174.

PMID:
25305215

Supplemental Content

Support Center